| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | immunoglobulin production | IGLV5-39 IGLV1-50 IGLV1-40 IGLV1-36 SASH3 IGKV3D-15 IGKV3D-11 IGKV2D-30 TNFAIP3 IGKV3-20 IGKV3-15 IGKV2-30 IGKV2-24 | 4.88e-08 | 241 | 159 | 13 | GO:0002377 |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | IGLV5-39 IGLV1-50 IGLV1-40 IGLV1-36 SASH3 IGKV3D-15 IGKV3D-11 IGKV2D-30 TNFAIP3 IGKV3-20 IGKV3-15 IGKV2-30 IGKV2-24 | 1.53e-05 | 403 | 159 | 13 | GO:0002440 |
| GeneOntologyCellularComponent | immunoglobulin complex | IGLV5-39 IGLV1-50 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV2-30 IGKV2-24 | 5.96e-08 | 166 | 159 | 11 | GO:0019814 |
| GeneOntologyCellularComponent | IgM immunoglobulin complex, circulating | 2.20e-07 | 8 | 159 | 4 | GO:0071754 | |
| GeneOntologyCellularComponent | pentameric IgM immunoglobulin complex | 2.20e-07 | 8 | 159 | 4 | GO:0071756 | |
| GeneOntologyCellularComponent | monomeric IgA immunoglobulin complex | 3.94e-07 | 9 | 159 | 4 | GO:0071748 | |
| GeneOntologyCellularComponent | polymeric IgA immunoglobulin complex | 6.53e-07 | 10 | 159 | 4 | GO:0071749 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex, circulating | 6.53e-07 | 10 | 159 | 4 | GO:0071746 | |
| GeneOntologyCellularComponent | secretory IgA immunoglobulin complex | 6.53e-07 | 10 | 159 | 4 | GO:0071751 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex | 4.12e-06 | 15 | 159 | 4 | GO:0071745 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex | 4.12e-06 | 15 | 159 | 4 | GO:0071753 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 7.10e-06 | 17 | 159 | 4 | GO:0042571 | |
| GeneOntologyCellularComponent | podocyte foot | 1.72e-04 | 3 | 159 | 2 | GO:0098846 | |
| GeneOntologyCellularComponent | nuclear body | MYC SP100 TOPBP1 JADE1 TRIP12 PALB2 WAC RMI1 SUGP2 GLI3 ELF2 WDFY3 BRD1 HEATR5B SRRM2 ZBTB18 | 1.47e-03 | 903 | 159 | 16 | GO:0016604 |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 4.43e-06 | 86 | 109 | 7 | M27206 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 4.78e-06 | 87 | 109 | 7 | M27205 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 7.31e-06 | 61 | 109 | 6 | M27581 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | STAB1 IGLV1-40 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 1.06e-05 | 98 | 109 | 7 | M27152 |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.50e-05 | 69 | 109 | 6 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 1.50e-05 | 69 | 109 | 6 | M27150 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 1.77e-05 | 71 | 109 | 6 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 1.77e-05 | 71 | 109 | 6 | M27203 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 3.00e-05 | 115 | 109 | 7 | M19752 | |
| Pathway | REACTOME_PARASITE_INFECTION | 3.18e-05 | 116 | 109 | 7 | M29843 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 3.51e-05 | 80 | 109 | 6 | M6121 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 4.04e-05 | 82 | 109 | 6 | M27110 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 5.30e-05 | 86 | 109 | 6 | M601 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 9.26e-05 | 95 | 109 | 6 | M29842 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.20e-04 | 143 | 109 | 7 | M27107 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 5.97e-04 | 186 | 109 | 7 | M27175 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 6.00e-04 | 134 | 109 | 6 | M29840 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 6.48e-04 | 136 | 109 | 6 | M27207 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MIIP TANC2 KIF26B IRS1 CBL TRIP12 SPICE1 SHKBP1 FSIP2 KCNQ5 CCDC138 OSBPL10 ANKRD17 NR3C2 MTCL1 TNFAIP3 BRD1 CAMSAP1 SRRM2 TNS3 DOP1A OTOG ANKS1A | 2.72e-11 | 861 | 166 | 23 | 36931259 |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 4691517 | ||
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 98179 | ||
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 99744 | ||
| Pubmed | 1.73e-08 | 7 | 166 | 4 | 9603450 | ||
| Pubmed | SRRM4 KIF21A PHRF1 TOPBP1 ADGRB3 TRIOBP JADE1 STAB1 TNRC6A FBXO41 ANKRD17 CDK5RAP2 ROBO2 PCNX1 ANKS1A | 4.32e-08 | 529 | 166 | 15 | 14621295 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB CDH26 TUT4 KCNH8 TRIM26 TRIOBP DYNC2I1 ARHGAP39 ATP10A BRWD3 CASK SHKBP1 COL23A1 ARHGAP6 PPARGC1B ASAP2 KCNQ5 SUGP2 NACC2 SETD5 ANKRD17 GREB1 VAV2 DOP1A ANKS1A | 4.64e-08 | 1489 | 166 | 25 | 28611215 |
| Pubmed | TANC2 MAPK8IP1 KIF21A ADGRB2 ADGRB3 TRIOBP ARHGAP39 MAP3K5 SPICE1 CASK IGF2R FBXO41 ANKRD17 CDK5RAP2 MTCL1 WDFY3 CAMSAP1 ANKS1A | 9.21e-07 | 963 | 166 | 18 | 28671696 | |
| Pubmed | MYC TANC2 SP100 TUT4 PHRF1 ZC3H3 BRWD3 TRIM66 SUGP2 SETD5 GLI3 RTL9 TNRC6A ANKRD17 WDFY3 KDM1B BRD1 SRRM2 UNC80 | 1.79e-06 | 1116 | 166 | 19 | 31753913 | |
| Pubmed | TANC2 FLNB FLT1 TRIOBP WAC IGF2R TENM3 ELAPOR1 PCNX1 MTCL1 FEM1A | 1.89e-06 | 371 | 166 | 11 | 15747579 | |
| Pubmed | FLNB TTLL5 TOPBP1 TRIP12 PALB2 SPICE1 CCDC138 ELF2 KDM1B BRD1 CAMSAP1 USP48 CDCA5 ARHGEF6 | 2.94e-06 | 645 | 166 | 14 | 25281560 | |
| Pubmed | 3.38e-06 | 48 | 166 | 5 | 11955599 | ||
| Pubmed | TANC2 THSD7A RNPC3 ARHGAP39 ATP10A ARSG WAC TRIM66 ASAP2 ELAPOR1 UNC80 DOP1A | 4.89e-06 | 493 | 166 | 12 | 15368895 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 ADGRB2 IRS1 JADE1 ARSG MAP3K5 PKMYT1 IGF2R KANSL1 SUGP2 SETD5 NEK8 PCNX1 TNFAIP3 WDFY3 CAMSAP1 FEM1A METTL27 | 6.25e-06 | 1105 | 166 | 18 | 35748872 |
| Pubmed | 1.36e-05 | 225 | 166 | 8 | 12168954 | ||
| Pubmed | IRS1/β-Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells. | 2.26e-05 | 2 | 166 | 2 | 27987331 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31300808 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 19597496 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 12218411 | ||
| Pubmed | Genome-wide association study identified copy number variants important for appendicular lean mass. | 2.26e-05 | 2 | 166 | 2 | 24626161 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 20674765 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25450678 | ||
| Pubmed | Human immunoglobulin kappa light chain genes of subgroups II and III. | 2.26e-05 | 2 | 166 | 2 | 2997711 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 11313921 | ||
| Pubmed | USP48 and A20 synergistically promote cell survival in Helicobacter pylori infection. | 2.26e-05 | 2 | 166 | 2 | 35913642 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25452429 | ||
| Pubmed | NEK8 regulates colorectal cancer progression via phosphorylating MYC. | 2.26e-05 | 2 | 166 | 2 | 37596667 | |
| Pubmed | MYC SP100 KIF26B CBL MAP3K5 ASAP2 KANSL1 TNRC6A ANKRD17 TNFAIP3 ZBTB18 | 2.39e-05 | 486 | 166 | 11 | 20936779 | |
| Pubmed | FLNB USP24 TOPBP1 CBL TRIP12 WAC C18orf21 MTCL1 SRRM2 CDCA5 ARHGEF6 | 3.27e-05 | 503 | 166 | 11 | 16964243 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 3.70e-05 | 420 | 166 | 10 | 28065597 | |
| Pubmed | DSC3 TRIOBP ARHGAP39 PPEF2 SPICE1 CASK SHKBP1 MTMR7 AAAS IGF2R CCDC138 TNRC6A MTMR2 CDK5RAP2 SRRM2 TNS3 | 4.62e-05 | 1049 | 166 | 16 | 27880917 | |
| Pubmed | 5.31e-05 | 84 | 166 | 5 | 34159380 | ||
| Pubmed | Small molecule Z363 co-regulates TAF10 and MYC via the E3 ligase TRIP12 to suppress tumour growth. | 6.77e-05 | 3 | 166 | 2 | 36639831 | |
| Pubmed | Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest. | 6.77e-05 | 3 | 166 | 2 | 21383696 | |
| Pubmed | Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1. | 6.77e-05 | 3 | 166 | 2 | 18923429 | |
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 21830225 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 9533023 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 15225653 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 34610962 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 20940296 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 26177020 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 29203640 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 10854852 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 30720110 | ||
| Pubmed | Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity. | 6.77e-05 | 3 | 166 | 2 | 33460648 | |
| Pubmed | The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1). | 6.77e-05 | 3 | 166 | 2 | 15001553 | |
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 15160911 | ||
| Pubmed | Immunoglobulin genes of different subgroups are interdigitated within the VK locus. | 6.77e-05 | 3 | 166 | 2 | 6440122 | |
| Pubmed | 6.91e-05 | 17 | 166 | 3 | 8223863 | ||
| Pubmed | 6.92e-05 | 209 | 166 | 7 | 36779422 | ||
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 7.39e-05 | 90 | 166 | 5 | 16273093 | |
| Pubmed | 7.61e-05 | 47 | 166 | 4 | 814163 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PHRF1 USP24 ARHGAP39 TRIP12 PALB2 SPICE1 KANSL1 SUGP2 ANKRD17 ELF2 SRRM2 ARHGEF6 ANKS1A | 9.48e-05 | 774 | 166 | 13 | 15302935 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FLNB KRT85 TRIP12 CASK SHKBP1 IGF2R OSBPL10 ANKRD17 MTCL1 TNFAIP3 KDM1B SRRM2 USP48 FEM1A KRT36 | 1.02e-04 | 1005 | 166 | 15 | 19615732 |
| Pubmed | 1.34e-04 | 102 | 166 | 5 | 10231032 | ||
| Pubmed | 1.35e-04 | 4 | 166 | 2 | 17962812 | ||
| Pubmed | Molecular characterization of the human immunoglobulin V lambda I germline gene repertoire. | 1.35e-04 | 4 | 166 | 2 | 1495496 | |
| Pubmed | 1.35e-04 | 4 | 166 | 2 | 12935897 | ||
| Pubmed | 1.35e-04 | 4 | 166 | 2 | 31930333 | ||
| Pubmed | 1.35e-04 | 4 | 166 | 2 | 12925573 | ||
| Pubmed | 1.35e-04 | 4 | 166 | 2 | 23818951 | ||
| Pubmed | 1.35e-04 | 4 | 166 | 2 | 29729186 | ||
| Pubmed | 1.35e-04 | 4 | 166 | 2 | 30770439 | ||
| Pubmed | Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses. | 1.35e-04 | 4 | 166 | 2 | 20208519 | |
| Pubmed | 1.35e-04 | 4 | 166 | 2 | 25611509 | ||
| Pubmed | FLNB THSD7A RNPC3 FAM161B TRIP12 CASK KANSL1 TENM3 TNFAIP3 BRD1 CAMSAP1 | 1.37e-04 | 591 | 166 | 11 | 15231748 | |
| Pubmed | 1.38e-04 | 163 | 166 | 6 | 24316575 | ||
| Pubmed | 1.67e-04 | 107 | 166 | 5 | 11347906 | ||
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 1.68e-04 | 322 | 166 | 8 | 39098523 | |
| Pubmed | 2.04e-04 | 421 | 166 | 9 | 36976175 | ||
| Pubmed | 2.24e-04 | 5 | 166 | 2 | 12857727 | ||
| Pubmed | Interaction of ASK1 and the beta-amyloid precursor protein in a stress-signaling complex. | 2.24e-04 | 5 | 166 | 2 | 17719230 | |
| Pubmed | Soluble M6P/IGF2R released by TACE controls angiogenesis via blocking plasminogen activation. | 2.24e-04 | 5 | 166 | 2 | 21273553 | |
| Pubmed | 2.24e-04 | 5 | 166 | 2 | 25387128 | ||
| Pubmed | 2.24e-04 | 5 | 166 | 2 | 11152963 | ||
| Pubmed | 2.24e-04 | 5 | 166 | 2 | 12234674 | ||
| Pubmed | 2.24e-04 | 5 | 166 | 2 | 11262396 | ||
| Pubmed | 2.24e-04 | 5 | 166 | 2 | 8854860 | ||
| Pubmed | 2.24e-04 | 5 | 166 | 2 | 22884659 | ||
| Pubmed | 2.87e-04 | 27 | 166 | 3 | 23740937 | ||
| Pubmed | Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. | 3.35e-04 | 6 | 166 | 2 | 27092474 | |
| Pubmed | A genome-wide association study of a coronary artery disease risk variant. | 3.35e-04 | 6 | 166 | 2 | 23364394 | |
| Pubmed | 3.35e-04 | 6 | 166 | 2 | 3351922 | ||
| Pubmed | 3.35e-04 | 6 | 166 | 2 | 16356860 | ||
| Pubmed | 3.35e-04 | 6 | 166 | 2 | 20100865 | ||
| Pubmed | 3.35e-04 | 6 | 166 | 2 | 12565902 | ||
| Pubmed | 3.35e-04 | 6 | 166 | 2 | 15581362 | ||
| Pubmed | Myc represses transcription through recruitment of DNA methyltransferase corepressor. | 3.35e-04 | 6 | 166 | 2 | 15616584 | |
| Pubmed | 4.13e-04 | 130 | 166 | 5 | 12421765 | ||
| Pubmed | MAPK8IP1 FLNB KIF21A TTLL5 ADGRB3 TRIOBP DYNC2I1 DNAAF9 TRIP12 BRWD3 WAC CASK STAB1 TRIM66 MTMR2 WDFY3 | 4.60e-04 | 1285 | 166 | 16 | 35914814 | |
| Pubmed | 4.67e-04 | 75 | 166 | 4 | 25593309 | ||
| Pubmed | 4.68e-04 | 7 | 166 | 2 | 8621483 | ||
| Pubmed | CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. | 4.68e-04 | 7 | 166 | 2 | 17255943 | |
| Pubmed | Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation. | 4.68e-04 | 7 | 166 | 2 | 20448643 | |
| Pubmed | 4.68e-04 | 7 | 166 | 2 | 29227477 | ||
| Pubmed | Myosin-reactive autoantibodies in rheumatic carditis and normal fetus. | 4.68e-04 | 7 | 166 | 2 | 9614934 | |
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | 5.16e-04 | 77 | 166 | 4 | 15608191 | |
| Pubmed | KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. | 6.22e-04 | 8 | 166 | 2 | 19727073 | |
| Pubmed | 6.22e-04 | 8 | 166 | 2 | 28322786 | ||
| Pubmed | 6.22e-04 | 8 | 166 | 2 | 9438420 | ||
| Interaction | YWHAG interactions | MIIP MYC TANC2 KIF26B KRT85 USP24 IRS1 PPEF2 CBL TRIP12 MAP3K5 SPICE1 SHKBP1 KCNQ5 OSBPL10 ANKRD17 MTCL1 TNFAIP3 BRD1 CAMSAP1 SRRM2 USP48 ARHGEF6 TNS3 DOP1A OTOG ANKS1A | 8.41e-07 | 1248 | 154 | 27 | int:YWHAG |
| Interaction | GSK3A interactions | MYC KIF26B KIF21A ARSG SPICE1 DEFA5 SUGP2 GLI3 CCDC138 TNRC6A MTCL1 CAMSAP1 SRRM2 TNS3 ANKS1A | 2.85e-06 | 464 | 154 | 15 | int:GSK3A |
| Interaction | PHIP interactions | 2.87e-06 | 197 | 154 | 10 | int:PHIP | |
| Interaction | YWHAH interactions | MIIP TANC2 KIF26B IRS1 CBL TRIP12 MAP3K5 SHKBP1 KCNQ5 CCDC138 OSBPL10 ANKRD17 NR3C2 MTCL1 TNFAIP3 BRD1 CAMSAP1 SRRM2 USP48 ARHGEF6 TNS3 DOP1A OTOG ANKS1A | 3.33e-06 | 1102 | 154 | 24 | int:YWHAH |
| Interaction | XYLT1 interactions | 1.77e-05 | 21 | 154 | 4 | int:XYLT1 | |
| Interaction | SFN interactions | MIIP MYC TANC2 KIF26B IRS1 JADE1 CBL TRIP12 MAP3K5 KCNQ5 NEK8 ANKRD17 CAMSAP1 SRRM2 TNS3 DOP1A ANKS1A | 2.29e-05 | 692 | 154 | 17 | int:SFN |
| Cytoband | 2p12 | IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 1.20e-08 | 117 | 166 | 8 | 2p12 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | MRPL35 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 9.48e-08 | 213 | 166 | 9 | chr2p11 |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 5.95e-08 | 83 | 116 | 8 | 351 |
| GeneFamily | PHD finger proteins | 2.46e-05 | 90 | 116 | 6 | 88 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 1.22e-04 | 3 | 116 | 2 | 912 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5 | DEFA5 IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 8.24e-07 | 183 | 152 | 10 | Arv_SC_fibroblast_1000_K5 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2 | DEFA5 IGLV1-40 IGKV2D-30 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-24 | 3.48e-05 | 126 | 152 | 7 | Arv_SC-HD_500_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | DEFA5 IGLV1-40 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-24 | 5.32e-05 | 183 | 152 | 8 | Arv_SC-HD_1000_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3 | DEFA5 IGLV1-40 IGKV2D-30 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-24 | 6.50e-05 | 139 | 152 | 7 | Arv_SC_fibroblast_500_K3 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.73e-12 | 177 | 163 | 12 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.73e-12 | 177 | 163 | 12 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.73e-12 | 177 | 163 | 12 | fc40918825b7e1eb6861df59dfca944778a64b98 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 3.12e-12 | 179 | 163 | 12 | 837ed81f18257f444eaeadc4fac89deedd4e3061 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 3.12e-12 | 179 | 163 | 12 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 3.12e-12 | 179 | 163 | 12 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 5.57e-12 | 188 | 163 | 12 | bd53b0371154cff680226897b61c9809a239d1b6 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | PKMYT1 ELL2 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.54e-10 | 152 | 163 | 10 | a2ba2d95ac9010e1a62db34dcad10d004f8a90cc |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | PKMYT1 IGLV1-50 ELL2 IGKV3D-15 IGKV2D-30 CDCA5 IGKV3-20 IGKV3-15 IGKV2-30 IGKV2-24 | 8.05e-10 | 171 | 163 | 10 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 |
| ToppCell | Control-Lymphoid-B_Plasma|Control / Disease state, Lineage and Cell class | IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 USP48 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 8.53e-10 | 172 | 163 | 10 | 61e33836b8cb0f347f3e699eb587a37073b6fa4c |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | IGLV1-50 IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV2D-30 USP48 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 1.01e-09 | 175 | 163 | 10 | d73ee324479172501481b54967a0f3bd870fcf3a |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 | 1.07e-09 | 176 | 163 | 10 | 4b4416f342b732d2cc60133838728880326257d8 |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 | 1.07e-09 | 176 | 163 | 10 | d895a6b295cd649273ff80ad7785a3e0ae4c728a |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PKMYT1 IGLV1-40 IGLV1-36 IGKV3D-11 IGKV2D-30 CDCA5 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-24 | 2.02e-09 | 188 | 163 | 10 | 6844cebca177fdf38b21a40d606230a033717a3a |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ELL2 IGLV1-40 IGKV3D-15 IGKV3D-11 TNFAIP3 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.35e-09 | 191 | 163 | 10 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 3.02e-09 | 196 | 163 | 10 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | IGLV1-50 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 1.31e-08 | 169 | 163 | 9 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | KCNH8 IGLV1-40 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.05e-08 | 178 | 163 | 9 | 107dae8b00c4257697a63700e72bb434cdb8406f |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.61e-08 | 183 | 163 | 9 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.87e-08 | 185 | 163 | 9 | 6ec009e48e50471c28e914c402f500e56a88f8f2 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.87e-08 | 185 | 163 | 9 | f49ad6401b2abd089e30eba245b11b5031ea2318 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.87e-08 | 185 | 163 | 9 | 08bc817908076734d66f2805cb954141f2cc5a18 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.87e-08 | 185 | 163 | 9 | 1704a12153a9b107bf03ecccd1a036cf61334d7a |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 3.00e-08 | 186 | 163 | 9 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | IGLV1-40 OSBPL10 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 3.29e-08 | 188 | 163 | 9 | c3cae529fdbeb233d2b32bcc3537a8aba26a7dc2 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ELL2 IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 3.61e-08 | 190 | 163 | 9 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ELL2 IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 3.61e-08 | 190 | 163 | 9 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.93e-08 | 197 | 163 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | MAPK8IP1 IRS1 DEFA5 IGLV1-40 OSBPL10 IGKV3-15 IGKV3-11 IGKV2-24 | 1.33e-07 | 159 | 163 | 8 | d3202ddc291b8686dbe67690df13c7daffec2199 |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-07 | 164 | 163 | 8 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | Control-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | IGLV1-36 IGKV3D-11 IGKV2D-30 USP48 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 2.22e-07 | 170 | 163 | 8 | fb05f49b7113470995b3c16683c54dc1a660b73a |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 2.54e-07 | 173 | 163 | 8 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | IGLV1-50 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 3.03e-07 | 177 | 163 | 8 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV1-50 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 3.59e-07 | 181 | 163 | 8 | e47664a264a2c37390d1668ce04eef2e0172f4cb |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 3.90e-07 | 183 | 163 | 8 | cf5c98f451a568308c52da5c926543dd4836c6b2 |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | IGLV1-50 ELL2 IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-11 IGKV2-24 | 4.06e-07 | 184 | 163 | 8 | 6f70d8f8ab8362d51f8a58735d42223e06566397 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-07 | 187 | 163 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.07e-07 | 194 | 163 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Biopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | IGLV1-50 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 6.31e-07 | 195 | 163 | 8 | d0305c6a68c9e361507b04db94f86873085d49b3 |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | IGLV1-50 IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 | 6.56e-07 | 196 | 163 | 8 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGLV1-50 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 6.56e-07 | 196 | 163 | 8 | fec21383435779bf4c632decd3d29c6ca7baebfb |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | KCNH8 IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 6.81e-07 | 197 | 163 | 8 | 88b29d205237f07a9a26cc15a1cf4ed4816a4c4b |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 6.81e-07 | 197 | 163 | 8 | 2662138671262b30508c5759038bcdcfe6551696 |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | IGLV1-50 ELL2 IGLV1-40 IGLV1-36 IGKV3D-11 CDCA5 IGKV3-20 IGKV3-11 | 6.81e-07 | 197 | 163 | 8 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | KCNH8 IGLV1-36 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 | 6.81e-07 | 197 | 163 | 8 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 7.08e-07 | 198 | 163 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.08e-07 | 198 | 163 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | PKMYT1 ELL2 IGLV1-40 OSBPL10 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 | 7.35e-07 | 199 | 163 | 8 | c11aa8bca3723a886e7082ae48bb922dd8396be4 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 7.35e-07 | 199 | 163 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 151 | 163 | 7 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.86e-06 | 157 | 163 | 7 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 2.48e-06 | 164 | 163 | 7 | 3b6a32ba53d05f6818fe950ac426f489383b645a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-06 | 167 | 163 | 7 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | IGLV1-50 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 2.80e-06 | 167 | 163 | 7 | f2185eb72f0137136f6d71af2a70168fded6c940 |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | IGLV1-50 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 2.80e-06 | 167 | 163 | 7 | 5e768cf24699893e05d1bcb1c92dba2336943a64 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 168 | 163 | 7 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | SASH3 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-15 IGKV3-11 IGKV2-30 | 3.41e-06 | 172 | 163 | 7 | d1ab8f493b70ec995281f9fb0991f1d3aa7b928f |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | IGLV1-40 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 IGKV2-24 | 3.96e-06 | 176 | 163 | 7 | 50e207403d48ce1b55a78897adb5519a2430a626 |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | IGLV1-50 IGLV1-36 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 3.96e-06 | 176 | 163 | 7 | 683022c3400e951b26c2b49394dfd3cc415276fe |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | ELL2 IGKV3D-15 IGKV2D-30 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-24 | 4.11e-06 | 177 | 163 | 7 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 |
| ToppCell | COPD-Lymphoid-B_Plasma|COPD / Disease state, Lineage and Cell class | IGLV1-50 IGKV3D-11 IGKV2D-30 USP48 IGKV3-20 IGKV3-15 IGKV2-30 | 4.11e-06 | 177 | 163 | 7 | 1b872d3b1e0fca138362098590a634d748dfca60 |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | ELL2 IGKV3D-15 IGKV2D-30 IGKV3-20 IGKV3-11 IGKV2-30 IGKV2-24 | 4.11e-06 | 177 | 163 | 7 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 4.60e-06 | 180 | 163 | 7 | cd04d7bf92986a5b8a0193c9b92ec47da3929bac |
| ToppCell | cellseq-Immune-Lymphocytic_B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 4.60e-06 | 180 | 163 | 7 | 663a800ab70e7ab7d13183417f9c1ed36907aa5e |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.60e-06 | 180 | 163 | 7 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.50e-06 | 185 | 163 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma|Liver / Manually curated celltypes from each tissue | 5.70e-06 | 186 | 163 | 7 | a2c7430781f432c9c90ac4d620f4518ff767a223 | |
| ToppCell | COVID-19-lung-Plasmablasts|lung / Disease (COVID-19 only), tissue and cell type | IGLV1-40 IGLV1-36 KCNQ5 IGKV3D-11 IGKV3-15 IGKV3-11 IGKV2-30 | 5.70e-06 | 186 | 163 | 7 | 81caf67da9fed09c77b7ddcab9b0b8e4fab2de97 |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | IGKV3D-15 IGKV3D-11 IGKV2D-30 CDCA5 IGKV3-20 IGKV3-15 IGKV3-11 | 5.70e-06 | 186 | 163 | 7 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-06 | 186 | 163 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.90e-06 | 187 | 163 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.33e-06 | 189 | 163 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.33e-06 | 189 | 163 | 7 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | COVID-19-lung-Plasmablasts|COVID-19 / Disease (COVID-19 only), tissue and cell type | IGLV1-40 IGLV1-36 KCNQ5 IGKV3D-11 IGKV3-15 IGKV3-11 IGKV2-30 | 6.33e-06 | 189 | 163 | 7 | fdf6c945b352614885e646a5ef4bc576dee73895 |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 6.55e-06 | 190 | 163 | 7 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.55e-06 | 190 | 163 | 7 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.02e-06 | 192 | 163 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.02e-06 | 192 | 163 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 7.26e-06 | 193 | 163 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.26e-06 | 193 | 163 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | ELL2 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 | 7.26e-06 | 193 | 163 | 7 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 7.26e-06 | 193 | 163 | 7 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.51e-06 | 194 | 163 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.51e-06 | 194 | 163 | 7 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ELL2 IGLV1-40 IGKV3D-15 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 | 7.51e-06 | 194 | 163 | 7 | f083777353e76a2d9c39f8b6cb1a689b68b81c56 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-06 | 194 | 163 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | FSIP2 IGLV1-40 IGKV3D-11 IGKV3-20 IGKV3-15 IGKV3-11 IGKV2-30 | 7.76e-06 | 195 | 163 | 7 | 600174e35574fe7c44dd923adcf43686e7b01e39 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.76e-06 | 195 | 163 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.76e-06 | 195 | 163 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.76e-06 | 195 | 163 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.03e-06 | 196 | 163 | 7 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGLV1-50 IGKV3D-15 IGKV3D-11 IGKV2D-30 IGKV3-20 IGKV3-15 IGKV3-11 | 8.03e-06 | 196 | 163 | 7 | c38e7f533c619afe008de0e99042f7180c2da918 |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 8.03e-06 | 196 | 163 | 7 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.03e-06 | 196 | 163 | 7 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.30e-06 | 197 | 163 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 197 | 163 | 7 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-06 | 197 | 163 | 7 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-06 | 197 | 163 | 7 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.57e-06 | 198 | 163 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.57e-06 | 198 | 163 | 7 | 2591e08e3fbee86ac40f11becd8147d6d39fded6 | |
| Disease | Neurodevelopmental Disorders | 7.66e-06 | 93 | 148 | 6 | C1535926 | |
| Disease | cortical surface area measurement | TANC2 FLNB KIF26B AMZ1 TRIOBP DNAAF9 ARHGAP39 PKMYT1 KANSL1 GLI3 RP1L1 TNRC6A MTMR2 ROBO2 ELF2 NR3C2 MTCL1 BRD1 ZBTB18 ANKS1A | 1.36e-05 | 1345 | 148 | 20 | EFO_0010736 |
| Disease | factor VIII measurement, coronary artery disease | 2.69e-04 | 113 | 148 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 2.92e-04 | 115 | 148 | 5 | EFO_0001645, EFO_0004694 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 2.95e-04 | 26 | 148 | 3 | EFO_0007870 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 3.29e-04 | 118 | 148 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | Mental Retardation, X-Linked | 4.11e-04 | 29 | 148 | 3 | C1136249 | |
| Disease | age at diagnosis, osteoarthritis | 5.16e-04 | 7 | 148 | 2 | EFO_0004918, MONDO_0005178 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 6.52e-04 | 137 | 148 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | nephroblastoma (is_marker_for) | 6.60e-04 | 34 | 148 | 3 | DOID:2154 (is_marker_for) | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 6.86e-04 | 8 | 148 | 2 | C0796250 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 8.79e-04 | 9 | 148 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | response to radiation | 1.02e-03 | 88 | 148 | 4 | GO_0009314 | |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 1.02e-03 | 88 | 148 | 4 | EFO_0000341, EFO_0006527 | |
| Disease | cervical cancer | 1.07e-03 | 40 | 148 | 3 | MONDO_0002974 | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.10e-03 | 10 | 148 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | fibrinogen measurement, coronary artery disease | 1.10e-03 | 154 | 148 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | vital capacity | CACNA1S COL6A3 FLT1 AMZ1 TRIP12 TRIM66 RMI1 KANSL1 KCNQ5 GLI3 RTL9 MTCL1 ARHGEF6 OTOG ANKS1A | 1.42e-03 | 1236 | 148 | 15 | EFO_0004312 |
| Disease | breast cancer (biomarker_via_orthology) | 1.88e-03 | 13 | 148 | 2 | DOID:1612 (biomarker_via_orthology) | |
| Disease | familial hyperlipidemia | 2.03e-03 | 106 | 148 | 4 | MONDO_0001336 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 2.19e-03 | 14 | 148 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | coronary artery disease, factor VII measurement | 2.40e-03 | 111 | 148 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | Inherited oocyte maturation defect | 2.86e-03 | 16 | 148 | 2 | cv:CN238505 | |
| Disease | Lipidemias | 3.23e-03 | 17 | 148 | 2 | C1706412 | |
| Disease | Hyperlipidemia | 3.23e-03 | 17 | 148 | 2 | C0020473 | |
| Disease | metabolic syndrome | 3.44e-03 | 200 | 148 | 5 | EFO_0000195 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 3.63e-03 | 18 | 148 | 2 | OBA_2045175 | |
| Disease | Hemangiosarcoma | 3.63e-03 | 18 | 148 | 2 | C0018923 | |
| Disease | angina pectoris | 3.68e-03 | 125 | 148 | 4 | EFO_0003913 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 3.94e-03 | 63 | 148 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | esterified cholesterol measurement | 4.01e-03 | 128 | 148 | 4 | EFO_0008589 | |
| Disease | Congenital hernia of foramen of Morgagni | 4.04e-03 | 19 | 148 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 4.04e-03 | 19 | 148 | 2 | C0265700 | |
| Disease | cortical thickness | FLNB TRIOBP DNAAF9 STAB1 KANSL1 SETD5 GLI3 TNRC6A MTMR2 CDK5RAP2 ROBO2 MTCL1 ANKS1A | 4.08e-03 | 1113 | 148 | 13 | EFO_0004840 |
| Disease | brain connectivity measurement | 4.17e-03 | 400 | 148 | 7 | EFO_0005210 | |
| Disease | Coronary Arteriosclerosis | 4.30e-03 | 65 | 148 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 4.30e-03 | 65 | 148 | 3 | C1956346 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 4.35e-03 | 131 | 148 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 4.35e-03 | 131 | 148 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 4.35e-03 | 131 | 148 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 4.35e-03 | 131 | 148 | 4 | C3714758 | |
| Disease | citrulline measurement | 4.47e-03 | 20 | 148 | 2 | EFO_0009777 | |
| Disease | Adenocarcinoma of prostate | 4.47e-03 | 20 | 148 | 2 | C0007112 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.68e-03 | 67 | 148 | 3 | C3463824 | |
| Disease | Juvenile-Onset Still Disease | 4.84e-03 | 135 | 148 | 4 | C0087031 | |
| Disease | Congenital diaphragmatic hernia | 4.93e-03 | 21 | 148 | 2 | C0235833 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ACVRPSSSVTVACSG | 116 | Q6ZRM9 | |
| TCNPSTITGTLSRLS | 1261 | O60241 | |
| PRRRCASESSISSSN | 846 | O95696 | |
| SLSTRPSSGCAQVLS | 226 | Q9NRG9 | |
| TLGSASTSTPGRRSC | 151 | Q96FF9 | |
| NAAGTSRSESPVCSS | 296 | O00472 | |
| SRSESPVCSSRDAVS | 301 | O00472 | |
| ERPCGRSSSLSAANT | 116 | Q15052 | |
| AAASIRCSSRPSRDS | 136 | Q400G9 | |
| QCPLNATGTTSRRCS | 536 | O60242 | |
| VSRGSSRSSCSQRRP | 171 | P0DPF5 | |
| PVSRGSSRSSCSQRR | 176 | P0DPF6 | |
| AAPRRNSSASSSCHL | 101 | Q8N4C9 | |
| FTERSRPGVQISCSS | 311 | Q6RI45 | |
| ASTCSPSRASLLTGR | 81 | Q96EG1 | |
| GISRNSSSPCISGTT | 1231 | Q5JWR5 | |
| TSSPLSQNDSCTGRS | 856 | Q92625 | |
| RNRTCRPPSSSESSS | 76 | O75179 | |
| SSGQSVSSNQRPCSS | 206 | Q15517 | |
| SSRCSLEVSLNSPSA | 1386 | O14529 | |
| STSRQRSRGSPSSTC | 36 | A6NI87 | |
| CSSTPDNLSRTQSGS | 1386 | Q5T5Y3 | |
| RRFTPSCLTSGCSSI | 611 | O60312 | |
| SSATSTPCVSRLVTG | 1701 | Q96SN8 | |
| ACFTTSRATSARPSV | 476 | Q6ZP01 | |
| CRLSIDSQSSSSGPR | 206 | Q06710 | |
| SRQSRSGVPSSSCVF | 666 | Q9C0H5 | |
| TSVAGSPARCSRISH | 191 | Q9Y4B5 | |
| GERATLSCRASQSVS | 36 | A0A0A0MRZ8 | |
| RTFRCSQAGLSAVPS | 61 | A6NJW4 | |
| SSCERDSPSTSRQSP | 576 | O14936 | |
| GQPASISCRSSQSLV | 36 | A0A075B6S6 | |
| GISPCFSSRRSSEAS | 866 | P10071 | |
| SRCSVSSPSNTNNRS | 306 | P08235 | |
| ASPGASARFTCTLRS | 31 | A0A0G2JS06 | |
| GSEFRSRQIPASTCS | 211 | Q4ZG55 | |
| RVTISCTGSSSNIGA | 36 | A0A075B6I6 | |
| SICRSSQPLSGFSAR | 201 | Q9Y216 | |
| PRSSSFSCGSSRSVR | 491 | P78386 | |
| TTDRGTSTDSPCRRS | 226 | Q9UQF2 | |
| GQFCSNSSSIRRTAP | 381 | Q8WXT5 | |
| PTASSFTTRTAQCRN | 21 | O43150 | |
| RPTSIISFNSDCSAR | 1206 | Q2KJY2 | |
| DSLRTGRSRSSQSIC | 901 | Q9NR82 | |
| QSCSSGRSTTIRVRC | 806 | Q6UXG2 | |
| RTDTNSSPSRASVCG | 451 | Q8WVS4 | |
| TSSNEGRRDSPTQTC | 5651 | Q5CZC0 | |
| RSATTAGSRAVSALC | 26 | Q86Y22 | |
| RTSRAPSVATVGSIC | 2101 | O75369 | |
| STTGFVPCRRSSTSQ | 2141 | Q96RV3 | |
| RQRSSGGSSKALSTC | 226 | Q96R72 | |
| DTRGQVTSSCSSQRL | 116 | Q6PCE3 | |
| VAPSNTGSRTTSVRC | 281 | Q86SG6 | |
| TGLSCQGRSRTPART | 581 | Q9P1Y6 | |
| SSSSDGTCVAARTRP | 581 | Q7Z3B3 | |
| VCSSLPRRSAVSGTA | 401 | Q6B0I6 | |
| RSTSSSERASSPAQC | 621 | Q13614 | |
| CGSTRRCSSLNNLPS | 126 | Q96MY7 | |
| GERATLSCRASQSVS | 36 | A0A087WSY6 | |
| LQDTSCRSASGPTLS | 601 | Q6UVM3 | |
| SEGRSKPSSTCSARL | 231 | Q8NGS8 | |
| LSALRTSGSQARATC | 51 | Q01523 | |
| GSTSDCLFPRRSSAS | 401 | P35568 | |
| ASSPALSTCTESGRR | 226 | Q8N6F8 | |
| LRRSGGCSPSSDTVF | 261 | Q86SP6 | |
| SGTCTGQPSSRTSQK | 466 | Q86YC2 | |
| PASSRSASSILCSSG | 146 | O43182 | |
| SLGQVAVSTCFSPRR | 266 | C9JE40 | |
| LSTARFSDGRPCSSV | 821 | A1KZ92 | |
| RLGATSVTRACTTGS | 56 | Q8WWP7 | |
| GNGATTSTIRSSCLV | 1016 | Q9P2D3 | |
| SPSCTSTNRAAATGN | 231 | Q8NB78 | |
| TNTTSSRPRTECCSD | 136 | Q96M89 | |
| CTHPTQCRATSRSTG | 671 | Q14574 | |
| TPHSRSTRENTSRCS | 1766 | Q13698 | |
| STRENTSRCSAPATA | 1771 | Q13698 | |
| TPTCTNAASVSRSGA | 56 | A8K010 | |
| SSSTQKGRDPQCTSS | 386 | Q8NHY3 | |
| QLRPGSSSCTLSAST | 246 | Q9H1R2 | |
| SCSGGRSPTVRVSVV | 1876 | P12111 | |
| RGQSISVTSIRPCAA | 826 | P10643 | |
| RTTRTNSTPLRAACF | 111 | Q9BSK4 | |
| SRGSPSVSCSRLRQV | 21 | Q5TEA3 | |
| RGISSTTVTGRTCQS | 1511 | P08519 | |
| GTSSSSATLPITFRC | 386 | P48664 | |
| SVRSGKNSSPINCSR | 336 | Q15723 | |
| RQLQVISSSCGSTPS | 341 | Q8TF61 | |
| GDQPETRSVCSSRSS | 136 | A6NNE9 | |
| IRTCHRPSCTTEGTT | 181 | Q6UWN5 | |
| RARDCGEPSLSSTTT | 246 | Q8IXH8 | |
| GQPASISCRSSQSLV | 36 | A0A0C4DH68 | |
| GQPASISCRSSQSLV | 36 | P06310 | |
| GERATLSCRASQSVS | 36 | P04433 | |
| GERATLSCRASQSVS | 36 | P01624 | |
| GERATLSCRASQSVS | 36 | P01619 | |
| RVCVPSSASALGTAS | 506 | P22681 | |
| LSRQASTGSELCSPS | 141 | O75995 | |
| CNRAPSSQTVGATTS | 96 | Q8TDM5 | |
| SVFRTPTSGQSVSTC | 161 | Q32NC0 | |
| ICGSPSSARSVSQSR | 86 | W6CW81 | |
| SRVSSIRSVGSCRVP | 26 | O76013 | |
| AQKTSRSSSIPCSGS | 366 | O14830 | |
| SLTSVGQTRFRPDSC | 2286 | Q6ZRI0 | |
| RCSSPLTRSSGSSLA | 596 | A8MW92 | |
| GCPAATSSSSATRGR | 66 | Q99683 | |
| LQRQRTALTSSAGSC | 176 | Q9NQF3 | |
| TALTSSAGSCVRIPS | 181 | Q9NQF3 | |
| QLSSITSSRNPACSG | 2176 | P11717 | |
| TAPIRASASGARSTS | 1016 | Q8NET4 | |
| LKSRTPSRHSCSGSS | 881 | Q9UQ35 | |
| GTRTRNISCVVSDGS | 1361 | Q9UPZ6 | |
| AAPNPCSSSSRTTRR | 691 | Q9BU23 | |
| EAPRQRVTISCSGSS | 31 | A0A0B4J1U3 | |
| RVTISCTGSSSNIGA | 36 | P01703 | |
| ERCFTTGSSSNTIPT | 266 | Q9H9A7 | |
| ISNNRKCTSPRSSDT | 336 | P01106 | |
| GQFCSNSSSIRRTAP | 381 | Q5VV16 | |
| ETSSTSLSTSCPRGR | 56 | Q5JXC2 | |
| RQLCSRSRSSSGSSP | 846 | Q86YN6 | |
| STPRLTTSERNLTCG | 56 | Q9NZE8 | |
| SDSRGTSSSHCRPQE | 1146 | Q9C0A6 | |
| TSSSHCRPQENISSR | 1151 | Q9C0A6 | |
| STGQRVCSVRSVDGS | 526 | Q8TBC3 | |
| QRISPCSTLTSSTAS | 126 | Q9HCD6 | |
| NSSARSTCSLTPALA | 546 | Q9BTA9 | |
| SGTPQRTSVCRHSSC | 116 | Q9HB31 | |
| QERVSGVPSSCSSSS | 536 | Q6IE81 | |
| SSCTISSNGPGQRRE | 926 | Q68CZ2 | |
| RNAFTSVSSCSPSRA | 61 | P51688 | |
| SVSSCSPSRASLLTG | 66 | P51688 | |
| PSCSLAGRGVSSRSA | 31 | Q9BXB5 | |
| SSPSRATRDNPTTSC | 441 | Q9H2D6 | |
| SPSRATRDNPTTSCA | 491 | Q9H2D6 | |
| CSTVSPVSGINTRRS | 796 | Q8N0Z3 | |
| NTRRSSGATGNSCSP | 806 | Q8N0Z3 | |
| PQKASQTCSSSRGRA | 351 | Q9BWW9 | |
| TTPSATRSCSGLVQT | 191 | Q8N0U2 | |
| NLTTCGRPVETASTR | 411 | O95498 | |
| GSCSRSLASRAVQRS | 641 | Q8IXZ2 | |
| DASSISTSQRISCRP | 186 | Q96N58 | |
| TAKRSSPINSQSRTC | 241 | Q8N2C7 | |
| STSHRPRAASCRATA | 3306 | Q8IZQ1 | |
| TCSTACSTGTTRQRR | 541 | P60852 | |
| QPLAISRGCTSSSSL | 6 | Q96LT9 | |
| RTTQSTSRPKCARAS | 706 | P21580 | |
| STPSTCTSSQQGQRR | 626 | Q8IWN7 | |
| VSQQSPCGRATSSSR | 181 | O43557 | |
| LARTVGSTSTPRSRC | 446 | Q99640 | |
| ACSASTSRTVAIPSG | 1436 | Q7Z4S6 | |
| SSPAESCRSKVRGTS | 806 | Q5VZP5 | |
| TVASPCSSTESLSQR | 211 | Q99592 | |
| ETCSSSLRRGSGSQP | 466 | P23497 | |
| RSQSSESRPSSCESR | 191 | A7MD48 | |
| QASSGTCFPRKRISS | 941 | Q8IX01 | |
| DASSVSTSQRISCRP | 186 | Q8N4W9 | |
| TSSCARAARAPSATE | 201 | Q9GZW5 | |
| GTPISFSCSRTRAGE | 1821 | Q9NY15 | |
| SGRSSCLSSRSNSAL | 141 | Q9P273 | |
| SRCSVSPTGDLTITN | 366 | Q9HCK4 | |
| CRSCTTDVRPISGSR | 36 | Q12899 | |
| SSLSPGRRCNTFSDS | 11 | P86452 | |
| IRNRLSSSGSNCSSG | 1366 | Q9UPU5 | |
| RTFISSGRSLGCQPS | 96 | Q86YA3 | |
| ESVSARAPTCCSTGR | 11 | Q8N446 | |
| ERSASRASSRSPASC | 771 | P52735 | |
| CRVRSGPSFKSVNTS | 311 | P17948 | |
| GGRSCSSSSAVIVPQ | 31 | Q14669 | |
| QKTTGSCASTSRRGS | 326 | Q14669 | |
| SSSSGRTSGSLCPRD | 771 | O15016 | |
| SIRTRQSSECSESPS | 1411 | Q5TAX3 | |
| TRCSPVSSVGNSALL | 761 | Q86UV5 | |
| RSGCNSASSTPDSTR | 1096 | Q92547 | |
| QRGPVSSTSDSSTNC | 211 | Q8NDV7 | |
| CRISSATASGQKPTT | 1196 | Q6EMB2 | |
| SLSPICTRGSSSRNK | 726 | Q96L42 | |
| RSPGASVSSSLTSLC | 561 | Q9P206 | |
| RNTLANSCGTGIRSS | 386 | Q96BF6 | |
| NSCGTGIRSSTSDPS | 391 | Q96BF6 |